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Abstract 
 
Isoflavones class of phytoestrogens including, genestein, daidzein and formononetin found in 
human dietary and show wide range of biological effect. In this study the impact of these 
phytoestrogens on glucose uptake was investigated in Hepatocellular carcinoma (HepG2 cells), 
using, 2-(N-(7-nitrobenz-2-oxa-1, 3- diazol-4-yl) amino)-2-deoxyglucose and Omega FluoStar 
plate reader. Incubation of cells (104/ml, in 24 well plate at 37 °C in 5% CO2 / air) with three 
phytoestrogens at concentration of 10-4 M to 10-9M in two studies mood, short term treatment 
(one hour) and long term treatment (24 hours) revealed, daidzein stimulates uptake of glucose, 
with a greater effect after a short treatment of one hour compared with treatment 24 hours. The 
effect was broadly higher at the lower concentrations tried, 1 µM to 1nM, at which glucose 
uptake was increased four to five fold after a one hour treatment. Interestingly the higher 
concentrations tried, 10 and 100 µM, showed less effect. Longer treatments resulted in a lesser 
stimulation of glucose uptake, and a peak effect was found at 0.1 µM. genestein exerted slightly 
inhibitory effect after one hour treatment compared with control, with the exception of treatment 
at 1 µM, which stimulated uptake about three-fold compared with control. Longer treatments 
with 10-4M to 10-6 M genistein resulted in gradual increase in glucose uptake to 2.4 times more 
than control, and thereafter a decline. Overall there was significant difference in glucose uptake 
between short and long term treatments, as indicated by two-way ANOVA, but the differences 
depend on the concentration of genistein, with higher concentrations of 10 and 100 µM inducing 
greater uptake after 24 hours treatment but at lower concentrations, uptake was stimulated more 
after a one hour treatment. A short treatment with formononetin inhibited glucose uptake, while 
longer treatments had variable effects, with an approximately two fold stimulation across a range 
of concentrations.HepG2 cells showed a significant increase in glucose uptake after treatment 
with phytoestrogens compared to the control. 
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Introduction 
Diabetes is an endocrine disease 
characterised by a chronic increase in blood 
sugar levels caused by a deficiency of insulin 
production, which leads to type 1 diabetes, or 
by a loss of tissue response to insulin, which 
leads to type 2 diabetes. The disease leads to 
disruption of metabolism, vascular damage 
and damage to the nervous system, as well as 
damage to other organs and systems. Diabetes 
mellitus (DM) is an important public health 
concern that affects more than 170 million 
individuals worldwide. It is expected that the 
number of people suffering from diabetes in 
the UK will reach approximately 5 million, or 
almost 10% of the population, by 2025 and it 
is one of the leading causes of death 
worldwide (Abeeleh et al. 2009). Diabetes is a 
multi-organ disease independent of age, race 
and gender. Efforts have accordingly been 
increased towards developing and refining 
treatments as well as to addressing the 
underlying causes of the disease. Many parts 
of the world have a documented history of the 
use of phytochemicals to treat diabetes, and 
these can be an attractive and alternative to 
expensive pharmaceutical medicines. 
Accordingly there is an increasing interest in 
identifying new phytochemicals with proven 
pharmacological effects on diabetes. Dietary 
phytoestrogens have been shown to play a 
beneficial role in obesity and diabetes, so this 
study investigated the effect of phytoestrogens 
on glucose uptake. Three phytoestrogens 
(daidzein, formonontein and genestin, which 
are naturally occurring isoflavones) were 
chosen.  
 
 
Material and methods 
HepG2 cells were obtained from King’s 
College Medical School Liver Unit. DMEM 
(Dulbecco's Modified Eagle Medium) glucose 
free and with glucose, methanol, dimethyl 
sulfoxide (DMSO), Costar 24 well plates, 2-
(N-(7-nitrobenz-2-oxa-1, 3- diazol-4-yl) 
amino)-2-deoxyglucose (2-NBDG), daidzein, 
formonontein and genestin were obtained from 
Sigma Aldrich (Poole, Dorset, UK).  
 
Cell Culture 
The human hepatoma HepG2 cell line was 
used in this work, and was grown in DMEM 
with 11 mM glucose (Gibco) and 10% foetal 
calf serum. Glucose was added to 11 mM for 
most experiments unless otherwise stated. 
HepG2 cell cultures were started from frozen 
cells, using standard protocols (Hanaa et 
al.2011). A vial of cells was collected from 
liquid nitrogen storage and the lower half 
submerged in a water bath at 37 °C. After 
allowing to thaw until a small amount of ice 
remained in the vial (usually 1-2 minutes), the 
vial was transferred to a sterile safety cabinet. 
The vial was wiped with a tissue moistened with 
70% alcohol, the cap removed and the cells were 
removed by slow pipetting to pre-warmed 
growth medium. The cells were centrifuged at 
1000 rpm at room temperature for 5 minutes to 
remove the DMSO in the cryopreservation 
medium. The medium was carefully removed 
and replaced with new medium and the cells 
slowly pipetted to a flask. Cells were grown at 
37 °C in 5% CO2 / air. 
The HepG2 cell line is anchorage 
dependent and must be cultured while attached  
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to a solid or semi-solid substrate (adherent or 
monolayer culture). The fibroblastic 
morphology of the cells was examined by 
microscopy at each sub-culture 
 
Glucose uptake in HepG2 cells 
For in vitro glucose uptake assays using 2-
NBDG, it was important to optimize the 
conditions of uptake of 2-NBDG by HepG2. 2-
NBDG is a fluorescent derivative of glucose 
modified with a 2-[N-(7-nitrobenz-2-oxa-1, 3-
diazol-4-yl) amino group at the C-2 position 
(Molecular Weight = 342.26) (Yoshioka 
1996).  The probe shows intense fluorescence 
at 542 nm when excited at 467 nm. 5mg 2-
NBDG was dissolved in 1.46 mL of methanol 
in order to make a 10mM as a stock solution. 5 
mM, 1 mM, 0.5 mM and 0.1mM solutions 
were prepared in methanol, as shown in Table 
2.1. Methanol only was used as a vehicle 
control. 
 
Table 2.1- Dilutions of 2NBDG used for optimising the uptake assay. 
Final concentration of 2-NBDG (mM) Stock/Vol. Vol MeOH 
5 10mM/100 µL 100µL 
1 5mM/40 µL 160 µL 
0.5 1mM/100 µL 100 µL 
0.1 0.5Mm/40 µL 160 µL 
 
 
HepG2 cells were sub-cultured using 
DMEM medium with glucose, 10mL of 
medium was added and cells were transferred 
into flasks, cells were seeded at a density 5.0 
x104 cells per mL and incubated with 10 mL 
of medium. Cells were counted using a 
haemocytometer and diluted to 0.5 x 105 
cells/mL. Then the cells were aliquotted at 0.5 
mL per well in a 24-well plate and incubated 
for 24 hours. 5 µL of 0, 0.1, 0.5, 1, 5, or 10 
mM 2-NBDG , was added to columns one to 
six respectively (from right to left), so that the 
2-NBDG was diluted 100 times. Cells were 
incubated at 37 °C for 15 minutes then washed 
with PBS and fluorescent uptake was 
measured using an Omega FluoStar (BMG 
LabTech, Ayelsbury, Bucks, UK) plate reader 
with λex = 485nm, λem = 530nm, using the 
bottom optic and a gain of 1000. 
Various modifications of the procedure 
were tried. One involved replacing normal 
medium with glucose-free medium after 24 
hours. Another concern was the optimal period 
of incubation with 2-NBDG, and uptake was 
accordingly monitored from 15 minutes to 2 
hours. The glucose uptake increase was 
checked by fluorescence microscopy. 
 
Glucose uptake measurement after treating 
confluent HepG2 cells with three 
phytoestrogens. 
This part of the project was started by 
making serial dilutions of three phytoestrogens 
genestein, daidzein and formononetin (Sigma 
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Aldrich, UK). Stock solutions of 10 mM, 1 
mM, 100 µM, 10 µM, 1 µM, and 0.1 µM were 
prepared in DMSO. HepG2 cells were cultured 
and treated as described in section 2.4. 
 
Results 
Glucose uptake measurement in HepG2 
cells treated with daidzein genestein and 
formononetin. 
HepG2 cells were cultured and seeded in a 
24 well plate at a concentration of 0.5x105 
cells/mL, and the next day the cells were 
treated with 5 µL daidzein, genestein and 
formononetin, with six different 
concentrations, started from 10-4 M to 10-9M. 
For short-term treatments the cells were 
incubated only for one hour after treatment, 
while for long term treatment the cell were 
treated for 24 hours. After the treatment period 
the medium was replaced with glucose free 
medium and 2-NBDG added. The 
measurement was performed after 15 minutes 
of incubation with the fluorescent analogue. 
 
Discussion and Conclusion 
Analysing the hypoglycaemic effect of 
phytoestrogens was purpose of this work 
where we applied the optimised method for 
usage of 2-NBDG to assess glucose uptake 
effect of the phytoestrogens. HepG2 cells were 
treated with Isoflavones phytoestrogens 
including daidzein, genistein and 
formonontein and each treatment was 
separately performed and analysed. The 
daidzein data, Fig.1.1 revealed that in both 
modes of study the uptake were stimulated and 
all the concentrations exerted increased effect 
on the uptake. However a better effect came 
from short term treatment, and concentration 
of 10-9 M is the most potent treatment. With 
genistein (Fig. 1.2) the situation is different, as 
in both modes of study, the change in glucose 
uptake fluctuated. In the one hour test the only 
concentration of genistein that showed an 
increase effect on the uptake was 10-6 M and it 
was about 2 times more than control. The rest 
of the concentrations did not have a positive 
effect on glucose consumption in HepG2 cells. 
In long treatments only two of the genistein 
concentrations appeared to have a positive 
effective on modulating the uptake, 10-6 M and 
10-5 M. 
The information from formonontein assay 
and its effect on glucose uptake (Fig 1.3), 
shows that only the long term method of 
treatment can stimulate the consumption of 
glucose, where the lowest concentration 10-9 M 
is the most potent compared with the rest of 
concentrations, and increased the uptake 
around 2.5 times more than control. 
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Figure 1.1- Effect of daidzein on glucose consumption in HepG2 cells. Uptake of the fluorescent glucose analogue 2-NBDG 
was measured in HepG2 cells treated with daidzein forr short and long term periods at the indicated concentrations and compared to control 
untreated cells. The data are mean+S.D. of three independent experiments in triplicate. P**** < 0.0001 comparing duration of treatment, 
P****<0.0001 comparing daidzen with control, as determined by two-way ANOVA. 
 
 
Figure 1.2- Evaluation of genistein on glucose uptake in HepG2 cells. Glucose consumption test was performed in 
HepG2 cells treated with range of genistein concentrations from 10-4 M to 10-9M, for one hour and 24 hour compared with 
untreated control. The data are mean+S.D. of three independent experiments in triplicate. P**** < 0.0001 comparing 
duration of treatment, P****<0.0001 comparing genistein with controls determined by two-way ANOVA. 
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Figure 1.3- Effect of formononetin effect on glucose uptake in HepG2 cells. Glucose uptake measured in HepG2 
cells after short and long treatments with six different concentrations of formononetin compared with untreated control. The 
data are mean+S.D. of three independent experiments in triplicate. P**** 0.0001 comapring duration of treatment, 
P***<0.0001 as determined by two-way ANOVA. 
 
The effect of phytoestrogens, mainly in 
type 2 diabetes, have been extensively studied 
previously (Jayagopal et al. 2002; Azadbakht 
et al. 2008; Hermansen et al. 2001; Liu et al. 
2010; Clerici et al. 2011; Anderson et al. 
1998; Teixeira et al. 2004; Gobert et al. 2010). 
In this work we assessed the effect of daidzein, 
genistein and formonontein on glucose uptake 
in an in vitro study. The finding in this section 
in terms of the isoflavones’ hypoglycaemic 
effect is supported by previous studies. 
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